Volitionrx
Yahoo Finance • 8 days ago
Volition's Capture-Seq Shows Over 95% Detection Of Early-Stage Cancers; Stock Up
(RTTNews) - VolitionRx Limited's (VNRX) breakthrough liquid biopsy technology, Capture-Seq, has delivered striking proof-of-concept results, detecting more than 95% of stage I and stage II cancers in a blinded validation cohort. The compa... Full story
Yahoo Finance • 5 months ago
VolitionRx signals transformative period as new partnerships target $85M APS market and drive 32% revenue growth
Earnings Call Insights: VolitionRx Limited (VNRX) Q3 2025 MANAGEMENT VIEW * Cameron Reynolds, CEO, announced, "2025 efforts for Volition have focused on commercializing our groundbreaking Nu.Q platform in the human diagnostic market, a... Full story
Yahoo Finance • 6 months ago
VolitionRx announces pricing of $6M underwritten public offering of common stock and common stock warrants
* VolitionRx (NYSE:VNRX [https://seekingalpha.com/symbol/VNRX]) on Friday announced the pricing of an underwritten public offering of 11.5M shares of its common stock and warrants to purchase up to 11.5M shares of its common stock. * T... Full story
Yahoo Finance • 6 months ago
VolitionRx proposes underwritten public offering of common stock, common stock warrants
* VolitionRx (NYSE:VNRX [https://seekingalpha.com/symbol/VNRX]) is proposing to offer and sell, in an underwritten public offering, shares of its common stock and accompanying common stock purchase warrants. * The final terms of the pr... Full story
Yahoo Finance • 8 months ago
Volitionrx Ltd earnings missed by $0.01, revenue fell short of estimates
Investing.com - Volitionrx Ltd (NYSE: VNRX) reported second quarter EPS of $-0.060, $0.01 worse than the analyst estimate of $-0.047. Revenue for the quarter came in at $406.69K versus the consensus estimate of $537.62K. Volitionrx Ltd’... Full story
Yahoo Finance • 8 months ago
VolitionRX reports Q2 results
* VolitionRX press release [https://seekingalpha.com/pr/20201938-volitionrx-limited-announces-second-quarter-2025-financial-results-and-business-update] (NYSE:VNRX [https://seekingalpha.com/symbol/VNRX]): Q2 Recorded just over $0.4 milli... Full story
Yahoo Finance • 9 months ago
VolitionRx files to sell 23.44M shares of common stock by selling shareholders
* VolitionRx (NYSE:VNRX [https://seekingalpha.com/symbol/VNRX]) filed a prospectus to sale 23.44 million shares of common stock. * The company will not receive any proceeds from the sale of ordinary shares by the selling shareholder.... Full story
Yahoo Finance • 3 years ago
Keynotes, Educational Panels and 77 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 25-27, 2023 at the Horseshoe Hotel & Casino in Las Vegas, NV
LAS VEGAS, NV / ACCESSWIRE / April 24, 2023 / Planet MicroCap presents the Planet MicroCap Showcase: VEGAS taking place on April 25-27, 2023, where 77 MicroCap public and private companies will be presenting at the Horseshoe Hotel & Casino... Full story
Yahoo Finance • 4 years ago
VolitionRx Limited Announces Pricing of $6 Million Underwritten Public Offering of Common Stock
HENDERSON, Nev., July 29, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announced today the pricing of its underwritten public offering of 3,000,000 shares of its common s... Full story
Yahoo Finance • 4 years ago
UPDATE -- Diamond Equity Research to Host Emerging Growth Invitational Virtual Investor Conference on June 23, 2022
NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading small-capitalization equity research and conference provider, will host its quarterly Emerging Growth Invitational investor conference on June 23, 2022. The... Full story
Yahoo Finance • 4 years ago
Diamond Equity Research to Host Emerging Growth Invitational Virtual Investor Conference on June 23, 2022
NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading small-capitalization equity research and conference provider, will host its quarterly Emerging Growth Invitational investor conference on June 23, 2022. The... Full story
